Essential Pharma

Greater London Legal Chronicle. February 16, 2024

Essential Pharma’s Acquisition of European Rights to Colobreathe

By Georgio Naffaa

In UK Taylor Wessing, advised on the matter. Taylor Wessing advised Essential Pharma with a team including Suzy Davis (Picture – Corporate M&A), Colin McCall (IP&IT),...

This content is for members only.
Join Now

Already a member? Log in here

ALK-Abelló A/S’ Licensing Agreement with ARS Pharmaceuticals Inc.

LDC’s Investment in LendingMetrics

SIX Exchange Group AG’s Acquisition Of Aquis Exchange Plc

Christies Care’s Acquisition of Daisy Chain Home Support

Becky Adlington and Steve Parry Business Swim!’s MBO From JD Gyms Group

Lisheen H2 Energy Park Limited’s Agreement With Clean Power Hydrogen Group

Coigach Community Development Company’s Acquisition Of 7,900 Acres Of Tenanted Croft Land And Common Grazings

Robert P. Slight & Sons’ Sale to EOT

Connelly Group Holdings’ Acquisition of Scottish Security & Fire Systems

RoundShield’s Closing of Private Credit Fund RS Fund V

Deep Blue’s Launch of the First Stablecoin of DBUSD in Jersey

Phoenix Equity Partners’ £200 Million Launch of Growth Partnership Fund

TLT Appoints Madi Dacwy as a Partner In Its Projects, Infrastructure and Construction Team

McDermott Strengthens Global Private Equity Offering With New Hire in London

Curtis Boosts London Finance and Corporate Capability with Appointment of Partner Christopher Harrison

Essential Pharma’s Acquisition of European Rights to Colobreathe